Stock PerformanceManagement's commentary about excess stock buyback plans should tactically help support the stock.
Strategic PartnershipsIQV appears to be well positioned for continued share gains, with 100% large pharma strategic partnership retention and new strategic partnership wins.
Technology & Analytics Solutions (TAS) GrowthPositive improvements in the Technology & Analytics Solutions (TAS) segment continue to show signs of growth, exceeding the growth targets set by the company.